Clinical Trials List
2021-03-24 - 2022-10-11
Phase III
Recruiting5
ICD-10E08.8
Diabetes mellitus due to underlying condition with unspecified complications
ICD-10E09.8
Drug or chemical induced diabetes mellitus with unspecified complications
ICD-10E11.8
Type 2 diabetes mellitus with unspecified complications
ICD-10E13.8
Other specified diabetes mellitus with unspecified complications
ICD-9250.90
Diabetes with unspecified complication, Type II [non-insulin dependent type][NIDDM type][adult-onset type] or unspecified type, not stated as uncontrolled
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 許惠恒 無
- Harn-Shen Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
45~60 participants
-
Global
580 participants
